Search research articles
Contact Us
Filters
Showing results (1-10 of 158) with videos related to
Page
of 16
Sort By:
JACC. Advances
|
June 28, 2024
Statin Use in Heart Failure: A Rebirth?
R Scott Wright
Current Opinion in Cardiology
|
June 6, 2013
Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol
R Scott Wright
Mayo Clinic Proceedings
|
August 3, 2024
TAVR and the US Public Health Emergency: A Critical Evaluation of Care Delivery and the Importance of Public-Private Partnerships During the COVID-19 Pandemic
R Scott Wright
Mayo Clinic Proceedings
|
May 8, 2020
Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19
Taimur Sher, R Scott Wright
Mayo Clinic Proceedings
|
January 5, 2023
Decreasing Door-to-Diagnosis Time in Cardiac Amyloidosis: A Simple "One-Stop Shop" Approach
Martha Grogan, R Scott Wright
Journal of the American College of Cardiology
|
January 30, 2016
PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients
R Scott Wright, Joseph Murphy
Current Interventional Cardiology Reports
|
November 7, 2001
Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy
R. Scott Wright, Gregory W. Barsness
Journal of the American College of Cardiology
|
December 24, 2016
High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New Role
Allan S Jaffe, R Scott Wright
Mayo Clinic Proceedings
|
September 6, 2019
Mitigating Risk Patients With Dyslipidemia: A Statin a Day Does Not Always Keep the Doctor Away in Those With Elevated Triglycerides
R Scott Wright, Joseph G Murphy
Current Problems in Cardiology
|
July 11, 2006
Pathophysiology, diagnosis, and management of dyslipidemia
Gerald T Gau, R Scott Wright
Page
of 16
Search research articles
Search
Showing results (1-10 of 158) with videos related to
Sort By:
Page
of 16
JACC. Advances
|
June 28, 2024
Statin Use in Heart Failure: A Rebirth?
R Scott Wright
Current Opinion in Cardiology
|
June 6, 2013
Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol
R Scott Wright
Mayo Clinic Proceedings
|
August 3, 2024
TAVR and the US Public Health Emergency: A Critical Evaluation of Care Delivery and the Importance of Public-Private Partnerships During the COVID-19 Pandemic
R Scott Wright
Mayo Clinic Proceedings
|
May 8, 2020
Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19
Taimur Sher, R Scott Wright
Mayo Clinic Proceedings
|
January 5, 2023
Decreasing Door-to-Diagnosis Time in Cardiac Amyloidosis: A Simple "One-Stop Shop" Approach
Martha Grogan, R Scott Wright
Journal of the American College of Cardiology
|
January 30, 2016
PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients
R Scott Wright, Joseph Murphy
Current Interventional Cardiology Reports
|
November 7, 2001
Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy
R. Scott Wright, Gregory W. Barsness
Journal of the American College of Cardiology
|
December 24, 2016
High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New Role
Allan S Jaffe, R Scott Wright
Mayo Clinic Proceedings
|
September 6, 2019
Mitigating Risk Patients With Dyslipidemia: A Statin a Day Does Not Always Keep the Doctor Away in Those With Elevated Triglycerides
R Scott Wright, Joseph G Murphy
Current Problems in Cardiology
|
July 11, 2006
Pathophysiology, diagnosis, and management of dyslipidemia
Gerald T Gau, R Scott Wright
Page
of 16